Dow Jones

40 211,72

0,00%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

INSM

Insmed (INSM)

Insmed Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:INSM

<< Précédent 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
16/07/2013	13h02	Dow Jones News	U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH	NASDAQ:INSM	Insmed Inc
15/07/2013	22h58	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INSM	Insmed Inc
15/07/2013	22h09	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:INSM	Insmed Inc
15/07/2013	22h05	Marketwired	Insmed Announces Proposed Public Offering of Common Stock	NASDAQ:INSM	Insmed Inc
09/07/2013	22h58	Edgar (US Regulatory)	Certified Annual Shareholder Report for Management Investment Companies (n-csr)	NASDAQ:INSM	Insmed Inc
08/07/2013	14h00	Marketwired	Insmed to Present at the 8th Annual JMP Securities Healthcare Conference	NASDAQ:INSM	Insmed Inc
01/07/2013	13h50	Edgar (US Regulatory)	Mutual Fund Summary Prospectus (497k)	NASDAQ:INSM	Insmed Inc
01/07/2013	13h45	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INSM	Insmed Inc
01/07/2013	13h00	Business Wire	ARIKACE Meets Primary Endpoint of Non-Inferiority to TOBI in Phase 3 Clinical Trial in Europe & Canada to Treat Pseudomonas a...	NASDAQ:INSM	Insmed Inc
28/06/2013	22h36	Marketwired	Insmed to Report Top-Line Results From Phase 3 Clinical Trial of ARIKACE to Treat Pseudomonas Aeruginosa in Cystic Fibrosis	NASDAQ:INSM	Insmed Inc
28/06/2013	22h30	Marketwired	Insmed to Join the Russell Global(R) and Russell 3000(R) Indexes	NASDAQ:INSM	Insmed Inc
26/06/2013	22h54	Edgar (US Regulatory)	Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)	NASDAQ:INSM	Insmed Inc
06/06/2013	12h02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:INSM	Insmed Inc
24/05/2013	22h17	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:INSM	Insmed Inc
24/05/2013	22h16	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:INSM	Insmed Inc
14/05/2013	14h00	Marketwired	Insmed Granted Key Composition of Matter Patent Allowance for ARIKACE in Europe	NASDAQ:INSM	Insmed Inc
13/05/2013	14h00	Marketwired	Insmed to Present at the UBS Global Healthcare Conference	NASDAQ:INSM	Insmed Inc
10/05/2013	18h52	Marketwired	Insmed to Present at the Bank of America Merrill Lynch 2013 Health Care Conference	NASDAQ:INSM	Insmed Inc
08/05/2013	16h50	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:INSM	Insmed Inc
07/05/2013	13h32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:INSM	Insmed Inc
07/05/2013	13h30	Marketwired	Insmed Reports First Quarter Financial Results	NASDAQ:INSM	Insmed Inc
01/05/2013	14h00	Marketwired	Insmed to Host First Quarter 2013 Financial Results Conference Call on Tuesday, May 7, 2013	NASDAQ:INSM	Insmed Inc
18/04/2013	23h02	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:INSM	Insmed Inc
18/04/2013	14h00	Marketwired	Insmed to Present at the 12th Annual Needham Healthcare Conference	NASDAQ:INSM	Insmed Inc
04/04/2013	18h15	Zacks	Orphan Status for Insmed's Arikace - Analyst Blog	NASDAQ:INSM	Insmed Inc
03/04/2013	22h31	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:INSM	Insmed Inc
01/04/2013	22h33	Marketwired	Insmed Appoints Matthew Pauls as Chief Commercial Officer	NASDAQ:INSM	Insmed Inc
28/03/2013	13h00	Marketwired	ARIKACE Receives Orphan Drug Designation for Treating Infections Caused by Non-Tuberculous Mycobacteria	NASDAQ:INSM	Insmed Inc
27/03/2013	13h00	Marketwired	Insmed to Present at Future Leaders in the Biotech Industry Conference	NASDAQ:INSM	Insmed Inc
18/03/2013	12h41	Marketwired	Insmed Reports Fourth Quarter and Full Year 2012 Financial Results	NASDAQ:INSM	Insmed Inc